Kaijun Wang

发表

Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.

D. Adams, C. Meduri, J. Popma, 2016, Journal of the American College of Cardiology.

Vascular Hospitalization Rates and Costs in Patients With Peripheral Artery Disease in the United States

Deepak L. Bhatt, S. Duval, E. Mahoney, 2010, Circulation. Cardiovascular quality and outcomes.

Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery.

P. Serruys, F. Mohr, C. Macaya, 2011, The New England journal of medicine.

Cost-Effectiveness of Edoxaban vs. Warfarin in Patients with Atrial Fibrillation Based on Results of the ENGAGE AF - TIMI 48 Trial: Taiwanese Perspective.

R. Giugliano, D. Cohen, E. Magnuson, 2017, Value in health regional issues.

Predicting the EQ-5D utilities from the Kansas City Cardiomyopathy Questionnaire in patients with heart failure

G. Fonarow, J. Spertus, D. Cohen, 2021 .

Quality of Life After PCI With Drug-Eluting Stents in Coronary Artery Bypass Surgery

P. Serruys, F. Mohr, C. Macaya, 2012 .

One-Year Costs in Patients With a History of or at Risk for Atherothrombosis in the United States

Deepak L. Bhatt, Deepak L Bhatt, David J Cohen, 2008, Circulation. Cardiovascular quality and outcomes.

Abstract P233: Selecting Antiplatelet Therapy After Percutaneous Intervention for an Acute Coronary Syndrome: Weighing the Risks and Benefits of Prasugrel Versus Clopidogrel

J. Spertus, D. Cohen, Adam C Salisbury, 2011, Circulation: Cardiovascular Quality and Outcomes.

Cost-Effectiveness of Solitaire Stent Retriever Thrombectomy for Acute Ischemic Stroke: Results From the SWIFT-PRIME Trial (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke)

H. Diener, W. Hacke, R. Jahan, 2017, Stroke.

Perioperative beta-blocker therapy and mortality after major noncardiac surgery.

P. Lindenauer, E. Benjamin, B. Gutierrez, 2005, The New England journal of medicine.

Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery

P. Lindenauer, E. Benjamin, B. Gutierrez, 2004, JAMA.

Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndromes and Planned Percutaneous Coronary Intervention: Results From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction TRI

Irina Proskorovsky, David J. Cohen, Elizabeth M. Mahoney, 2010, Circulation.

Effects of Ranolazine on Disease-Specific Health Status and Quality of Life Among Patients With Acute Coronary Syndromes: Results from the MERLIN-TIMI 36 Randomized Trial

E. Braunwald, D. Morrow, B. Scirica, 2008, Circulation. Cardiovascular quality and outcomes.

Incidence, outcomes, and effect on quality of life of cranial nerve injury in the Carotid Revascularization Endarterectomy versus Stenting Trial.

T. Brott, Jenifer Voeks, M. Hill, 2015, Journal of Vascular Surgery.

Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease.

P. Serruys, M. Morice, D. Cohen, 2017, Journal of the American College of Cardiology.

Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective

D. van Klaveren, E. Steyerberg, P. Serruys, 2015, Heart.

Cost-Effectiveness of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel or Left Main Coronary Artery Disease: Final Results From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial

P. Serruys, F. Mohr, M. Morice, 2014, Circulation.

Cost-Effectiveness of Percutaneous Coronary Intervention with Drug-Eluting Stents vs. Bypass Surgery for Patients with 3-Vessel or Left Main Coronary Artery Disease: Final Results from the SYNTAX Trial

P. Serruys, F. Mohr, M. Morice, 2014 .

Predicting the EQ-5D from the Kansas City Cardiomyopathy Questionnaire (KCCQ) in Patients with Heart Failure.

G. Fonarow, J. Spertus, D. Cohen, 2021, European heart journal. Quality of care & clinical outcomes.

Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial

E. Antman, R. Giugliano, D. Cohen, 2017, Journal of the American Heart Association.

Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A).

M. Mack, J. Bavaria, L. Svensson, 2012, Journal of the American College of Cardiology.

Cost-Effectiveness of Transcatheter Aortic Valve Replacement Compared With Standard Care Among Inoperable Patients With Severe Aortic Stenosis: Results From the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort B)

W. O’Neill, M. Leon, Craig R. Smith, 2012, Circulation.

L. Goldstein, T. Brott, G. Howard, 2011, Journal of the American College of Cardiology.

Global Variation in the Prevalence of Elevated Cholesterol in Outpatients With Established Vascular Disease or 3 Cardiovascular Risk Factors According to National Indices of Economic Development and Health System Performance

Deepak L. Bhatt, E. Ohman, Sidney C. Smith, 2012, Circulation.

Cost-Effectiveness of Transcatheter Mitral Valve Repair versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial.

M. Mack, G. Stone, B. Whisenant, 2019, Circulation.

Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk: Results From the PARTNER 2 Trial

M. Mack, L. Svensson, M. Leon, 2019, Circulation.

Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 Trial.

Marc P. Bonaca, Deepak L. Bhatt, M. Sabatine, 2017, Journal of the American College of Cardiology.

Cost-Effectiveness of Percutaneous Coronary Intervention With Drug Eluting Stents Versus Bypass Surgery for Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease: Results From the FREEDOM Trial

Lynn A. Sleeper, David J. Cohen, Valentin Fuster, 2013, Circulation.

Indices of Economic Development and Health System Performance Established Vascular Disease or 3 Cardiovascular Risk Factors According to National Global Variation in the Prevalence of Elevated Cholesterol in Outpatients With

E. Ohman, Sidney C. Smith, P. Steg, 2012 .

Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial.

V. Fuster, J. Spertus, M. Farkouh, 2013, JAMA.

Do Differences in Repeat Revascularization Explain the Antianginal Benefits of Bypass Surgery Versus Percutaneous Coronary Intervention?: Implications for Future Treatment Comparisons

P. Serruys, F. Mohr, S. Arnold, 2012, Circulation. Cardiovascular quality and outcomes.

PCV64 INDEX, FOLLOW-UP AND TOTAL HOSPITALIZATION COSTS IN PATIENTS WITH ACUTE CORONARY SYNDROMES UNDERGOING PLANNED PERCUTANEOUS CORONARY INTERVENTION TREATED WITH PRASUGREL VS. CLOPIDOGREL IN THE TRITON-TIMI 38 TRIAL

E. Mahoney, S. Arnold, Y. Lei, 2008 .

Martin B Leon, David J Cohen, M. Leon, 2012, Journal of the American College of Cardiology.

M. Leon, Craig R. Smith, David L. Brown, 2012 .

Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial

M. Mack, L. Svensson, M. Leon, 2017, JAMA cardiology.

Durability of quality of life benefits of transcatheter aortic valve replacement: Long‐term results from the CoreValve US extreme risk trial

D. Adams, J. Popma, S. Arnold, 2017, American heart journal.

Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial.

D. Adams, J. Popma, T. Burdon, 2015, JACC. Cardiovascular interventions.

Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.

E. Tuzcu, M. Leon, D. C. Miller, 2018, JACC. Cardiovascular interventions.

Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation

M. Mack, G. Stone, J. Cleland, 2022, Heart.

Selecting Antiplatelet Therapy at the Time of Percutaneous Intervention for an Acute Coronary Syndrome: Weighing the Benefits and Risks of Prasugrel Versus Clopidogrel

J. Spertus, D. Cohen, Philip G. Jones, 2013, Circulation. Cardiovascular quality and outcomes.

Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement: A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy

A. Kirtane, M. Leon, S. Arnold, 2015, Circulation. Cardiovascular quality and outcomes.

Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 Trial

M. Leon, S. Kapadia, Craig R. Smith, 2023, Circulation.

Health Status after Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis.

M. Mack, M. Leon, S. Kapadia, 2019, Journal of the American College of Cardiology.

Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.

D. Adams, J. Popma, S. Arnold, 2015, JACC. Cardiovascular interventions.

Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes Vytorin Efficacy International Trial)

D. Mark, R. Giugliano, E. Braunwald, 2017, Circulation. Cardiovascular quality and outcomes.

Cost-effectiveness of edoxaban vs warfarin in patients with atrial fibrillation based on results of the ENGAGE AF-TIMI 48 trial.

E. Antman, R. Giugliano, D. Cohen, 2015, American heart journal.

W. O’Neill, M. Leon, Craig R. Smith, 2012, Circulation.

L. Goldstein, T. Brott, G. Howard, 2011, Journal of the American College of Cardiology.

Five-Year Clinical and Quality of Life Outcomes From the CoreValve US Pivotal Extreme Risk Trial

G. Deeb, N. Kleiman, S. Arnold, 2021, Circulation. Cardiovascular interventions.

Effects of Ranolazine on Disease-Specific Health Status and Quality of Life Among Patients With Acute Coronary Syndromes: Results from the MERLIN-TIMI 36 Randomized Trial

E. Braunwald, D. Morrow, B. Scirica, 2008, Circulation. Cardiovascular quality and outcomes.

Abstract 16534: Cost-Effectiveness of Edoxaban vs. Warfarin in Patients With Atrial Fibrillation: Results From the ENGAGE AF - TIMI 48 Economic Study

E. Antman, E. Magnuson, C. Ruff, 2014 .

V. Fuster, L. Sleeper, M. Farkouh, 2013, Circulation.